China’s National Medical Products Administration (NMPA) has approved Zeiss Medical Technology’s retinal imaging system, the ...

Targeting PDE4 drives anti-inflammatory and antifibrotic effects, and Boehringer has been working on its own PDE4 inhibitor ...

Cardiovascular disease and mental illness commonly co-occur. Addressing them together can improve both mental health and ...

The global canine arthritis treatment market stands at a valuation of USD 2.50 billion in 2024. Global demand for canine arthritis treatment medications is predicted to rise at a CAGR of 4.20% and ...

The newly formed advisory board, which held its inaugural meeting last month, will identify opportunities to enhance scientific capabilities to ensure that OXB remains at the forefront of developing ...

and acknowledges the leading position China has achieved in many scientific areas", said David Preston, President and CEO of Boehringer Ingelheim Greater China.

The large molecule drug substance CDMO market is anticipated to expand at a CAGR of ~9% during the forecast period. Key ...

Biologics Contract Manufacturing Market Explore the booming biologics contract manufacturing market, set to reach $83.47B by 2033, driven b ...

The Asia Society Policy Institute’s Center for China Analysis aims to become a leading global think tank committed to decoding China's complexities with an "inside-out" approach by offering ...

Regulatory Evolution and Product Innovation: Regulatory frameworks governing OTC pet medications are evolving to ensure ...